Post COVID-19 Organizing Pneumonia: The Right Time to Interfere

The COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persis...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Medicina (Kaunas, Lithuania) Ročník 57; číslo 3; s. 283
Hlavní autori:	Bieksiene, Kristina, Zaveckiene, Jurgita, Malakauskas, Kestutis, Vaguliene, Neringa, Zemaitis, Marius, Miliauskas, Skaidrius
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 18.03.2021 MDPI
Predmet:	Algorithms Asymptomatic Biopsy Computed Tomography Angiography Coronaviruses COVID-19 COVID-19 - complications COVID-19 - diagnosis COVID-19 - drug therapy COVID-19 - physiopathology COVID-19 vaccines Disease Management Early Diagnosis Glucocorticoids - therapeutic use Hospitalization Hospitals Humans Immunization Infections interstitial lung diseases Lung - diagnostic imaging Lung - pathology Lung - physiopathology Lung diseases Lung Diseases, Interstitial - diagnosis Lung Diseases, Interstitial - drug therapy Lung Diseases, Interstitial - etiology Lung Diseases, Interstitial - physiopathology Mortality Opinion organizing pneumonia Oxygen therapy Pandemics Patients Pneumonia Pulmonary Diffusing Capacity Pulmonary embolisms SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Spirometry systemic glucocorticoids Tomography, X-Ray Computed viral pneumonia Walk Test Lithuania COVID-19 organizing pneumonia systemic glucocorticoids interstitial lung diseases viral pneumonia
ISSN:	1648-9144, 1010-660X, 1648-9144
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Popis
Shrnutí:	The COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persistent or worsening respiratory symptoms and changes on chest X-ray following COVID-19 pneumonia. In this article, we talk about a subgroup of patients with organizing pneumonia following COVID-19 pneumonia that could be effectively treated with systemic glucocorticoids. It is important that patients with COVID-19 pneumonia be followed-up at least three weeks after diagnosis, in order to recognize early lung damage. We are providing a management algorithm for early diagnosis of lung diseases after COVID-19 pneumonia.
Bibliografia:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ISSN:	1648-9144 1010-660X 1648-9144
DOI:	10.3390/medicina57030283